中华实验外科杂志2024,Vol.41Issue(4) :679-682.DOI:10.3760/cma.j.cn421213-20230922-01336

金属硫蛋白1M通过调控磷脂酰肌醇3激酶/蛋白激酶B/上皮-间充质转化抑制三阴性乳腺癌细胞的迁移和侵袭

Metallothionein 1M inhibits migration and invasion of triple-negative breast cancer cells by regula-ting phosphatidylinositol-3-kinase-protein kinase B/epithelial mesenchymal transformation

李鑫 刘相萍 彭景 毛艳 王圆媛 马腾 隋爱华 韩亚斐 王海波
中华实验外科杂志2024,Vol.41Issue(4) :679-682.DOI:10.3760/cma.j.cn421213-20230922-01336

金属硫蛋白1M通过调控磷脂酰肌醇3激酶/蛋白激酶B/上皮-间充质转化抑制三阴性乳腺癌细胞的迁移和侵袭

Metallothionein 1M inhibits migration and invasion of triple-negative breast cancer cells by regula-ting phosphatidylinositol-3-kinase-protein kinase B/epithelial mesenchymal transformation

李鑫 1刘相萍 2彭景 1毛艳 1王圆媛 1马腾 1隋爱华 2韩亚斐 2王海波1
扫码查看

作者信息

  • 1. 青岛大学附属医院乳腺病诊疗中心,青岛 266003
  • 2. 青岛大学附属医院医学研究中心,青岛 266003
  • 折叠

摘要

目的 观察金属硫蛋白1M(MT1M)在三阴性乳腺癌(TNBC)细胞中的表达,探讨其对TNBC细胞迁移、侵袭的影响及机制.方法 利用Ualcan和Kaplan-Meier Plotter在线网站分析MT1M在TNBC和正常乳腺组织中的表达及MT1M表达水平与TNBC患者预后的关系.在TNBC细胞MDA-MB-231、BT-549中转染MT1M过表达质粒为MT1M过表达组,转染空载质粒为对照组.利用蛋白质印迹法(Western blot)验证转染后两组细胞中MT1M蛋白水平;通过划痕实验以及Transwell小室侵袭实验检测两组细胞的迁移和侵袭能力;利用Western blot检测两组细胞中E-钙黏蛋白(E-cadherin)、波形蛋白(Vimentin)、磷脂酰肌醇-3-激酶(PI3K)、蛋白激酶B蛋白(Akt)以及磷酸化的蛋白激酶B蛋白(p-Akt)水平,两组间比较采用t检验.结果 网站数据分析显示MT1M mRNA水平在TNBC中异常低表达,其异常低表达的患者预后也较差.MT1M过表达组MDA-MB-231、BT-549 细胞中 MT1M 蛋白表达(11.08±1.90、9.00±0.69)明显高于对照组(1.35±0.52、1.41± 0.43),差异有统计学意义(t=8.569、16.220,P<0.05).划痕实验结果显示MT1M过表达组MDA-MB-231 细胞划痕愈合率[12 h(25.46±10.31)%,24 h(44.55±23.65)%]均明显低于对照组[12h(33.07±9.28)%,24h(60.68±21.89)%],差异有统计学意义(t=4.426、8.202,P<0.05);MT1M 过表达组 BT-549 细胞划痕愈合率[24 h(30.40±11.52)%,48 h(64.01±7.28)%]均明显低于对照组[24h(57.21±11.98)%,48h(98.99±0.29)%],差异有统计学意义(t=6.780、8.660,P<0.05).Transwell小室实验结果显示MT1M过表达组MDA-MB-231、BT-549细胞穿过小室数目[(141.67±1.53)、(173.00±11.27)个]明显低于对照组[(339.67±61.86)、(376.00± 19.00)个],差异有统计学意义(t=5.678、17.390,P<0.05).MT1M 过表达组 MDA-MB-231、BT-549 细胞中 E-cadherin 蛋白表达(4.80±0.65、4.81±1.20)明显高于对照组(1.29±0.26、1.41± 0.68),差异有统计学意义(t=8.745、4.279,P<0.05).而 Vimentin、PI3K、Akt 以及 p-Akt 蛋白表达分别为 1.25±0.32、1.11±0.13;1.40±0.52、1.52±0.48;1.05±0.07、1.04±0.05;1.35±0.51、1.06±0.07,明显低于对照组(5.16±1.10、6.35±0.13;4.52±0.50、3.37±0.55;1.90±0.18、1.98±0.19;4.55±0.68、3.10±0.59),差异有统计学意义(t=5.932、48.250;7.525、4.420;7.614、8.466;6.524、5.961,P<0.05).结论 MT1M在三阴性乳腺癌细胞中呈低表达;MT1M可能通过调控PI3K-Akt/上皮-间充质转化影响三阴性乳腺癌细胞的迁移和侵袭.

Abstract

Objective To observe the expression of metallothionein 1M(MT1M)in triple-negative breast cancer(TNBC)cells,and study the effect and mechanism of MT1M on TNBC cell migration and inva-sion.Methods Ualcan and Kaplan-Meier Plotter online websites were used to analyze the expression of MT1M in TNBC and normal breast tissues and the relationship between MT1M expression level and the prog-nosis of TNBC patients.TNBC cells(MDA-MB-231 and BT-549)were transfected with MT1M overexpression plasmid as MT1M overexpression group,and TNBC cells transfected with empty plasmid as control group.Western blotting was used to verify the MT1M protein level in the transfected cells of the two groups.The mi-gration and invasion ability of cells was detected by scratch test and Transwell chamber test.Western blotting was used to detect the levels of E-cadherin,Vimentin,phosphatidylinositol-3-kinase(PI3K),protein kinase B(Akt)and phosphorylated protein kinase B(p-Akt)in the two groups.The t-test was used for comparison between the two groups.Results Website data analysis showed that MT1M mRNA was abnormally low in TNBC,and patients with abnormally low MT1M expression had poor prognosis.The protein expression of MT1M in MDA-MB-231 and BT-549 cells in MT1M overexpression group(11.08±1.90,9.00±0.69)was significantly higher than that in control group(1.35±0.52,1.41±0.43,t=8.569,16.220,P<0.05).The wound healing rate of MDA-MB-231 cells in MT1M overexpression group[12 h(25.46±10.31)%;24 h(44.55±23.65)%]was significantly lower than that in control group[12 h(33.07±9.28)%;24 h(60.68±21.89)%,t=4.426,8.202,P<0.05].The wound healing rate of BT-549 cells in MT1M overex-pression group[24 h(30.40±11.52)%;48 h(64.01±7.28)%]was significantly lower than that in con-trol group[24 h(57.21±11.98)%;48 h(98.99±0.29)%,t=6.780,8.660,P<0.05].Transwell as-say results showed that the number of MDA-MB-231 and BT-549 cells passing through(141.67±1.53,173.00±11.27)in the MT1M overexpression groups was significantly less than that in the control group(339.67±61.86,376.00±19.00,t=5.678,17.390,P<0.05).The expression of E-cadherin protein in MDA-MB-231 and BT-549 cells in MT1M overexpression group(4.80±0.65,4.81±1.20)was significantly higher than that in control group(1.29±0.26,1.41±0.68,t=8.745,4.279,P<0.05).The expression of Vimentin,PI3K,Akt and p-Akt was 1.25±0.32,1.11±0.13;1.40±0.52,1.52±0.48;1.05±0.07,1.04±0.05 and 1.35±0.51,1.06±0.07,significantly lower than the control group(5.16±1.10,6.35± 0.13;4.52±0.50,3.37±0.55;1.90±0.18,1.98±0.19;4.55±0.68,3.10±0.59,t=5.932,48.25;7.525,4.420;7.614,8.466;6.524,5.961,P<0.05).Conclusion The expression of MT1M was low in TNBC cells.MT1M may affect the migration and invasion of TNBC cells by regulating PI3K-Akt/epithelial mesenchymal transformation.

关键词

金属硫蛋白1M/三阴性乳腺癌/上皮-间充质转化/迁移/侵袭

Key words

Metallothionein 1M/Triple negative breast cancer/Epithelial mesenchymal trans-formation/Migration/Invasion

引用本文复制引用

基金项目

国家自然科学基金(81572616)

国家自然科学基金(81772845)

山东省自然科学基金(ZR2021MH158)

山东省自然科学基金(ZR2021MH119)

出版年

2024
中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
参考文献量6
段落导航相关论文